PreveCeutical Medical Inc. (FRA:18H0)
Germany · Delayed Price · Currency is EUR 0.0080
-0.0030 (-27.27%)
Last updated: Dec 1, 2025, 8:19 AM CET
PreveCeutical Medical Company Description
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.
Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).
The company is headquartered in West Vancouver, Canada.
PreveCeutical Medical Inc.
| Country | Canada |
| Industry | Pharmaceutical Preparations |
| CEO | Stephen Van Deventer |
Contact Details
Address: 5428 Marine Drive West Vancouver, British Columbia V7W 2R2 Canada | |
| Phone | 604 416 7777 |
| Website | preveceutical.com |
Stock Details
| Ticker Symbol | 18H0 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Stephen Van Deventer | Chief Executive Officer |
| Stephen Van Deventer | Chief Financial Officer |